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non-traumatic acromioclavicular joint pain
Angela Cadogan1*, Peter McNair1, Mark Laslett1 and Wayne Hing2Abstract
Background: Despite numerous methodological flaws in previous study designs and the lack of validation in
primary care populations, clinical tests for identifying acromioclavicular joint (ACJ) pain are widely utilised without
concern for such issues. The aim of this study was to estimate the diagnostic accuracy of traditional ACJ tests and
to compare their accuracy with other clinical examination features for identifying a predominant ACJ pain source in
a primary care cohort.
Methods: Consecutive patients with shoulder pain were recruited prospectively from primary health care clinics.
Following a standardised clinical examination and diagnostic injection into the subacromial bursa, all participants
received a fluoroscopically guided diagnostic block of 1% lidocaine hydrochloride (XylocaineTM) into the ACJ.
Diagnostic accuracy statistics including sensitivity, specificity, predictive values, positive and negative likelihood
ratios (LR+ and LR-) were calculated for traditional ACJ tests (Active Compression/O’Brien’s test, cross-body
adduction, localised ACJ tenderness and Hawkins-Kennedy test), and for individual and combinations of clinical
examination variables that were associated with a positive anaesthetic response (PAR) (P≤0.05) defined as 80% or
more reduction in post-injection pain intensity during provocative clinical tests.
Results: Twenty two of 153 participants (14%) reported an 80% PAR. None of the traditional ACJ tests were
associated with an 80% PAR (P<0.05) and combinations of traditional tests were not able to discriminate between a
PAR and a negative anaesthetic response (AUC 0.507; 95% CI: 0.366, 0.647; P>0.05). Five clinical examination
variables (repetitive mechanism of pain onset, no referred pain below the elbow, thickened or swollen ACJ, no
symptom provocation during passive glenohumeral abduction and external rotation) were associated with an 80%
PAR (P<0.05) and demonstrated an ability to accurately discriminate between an PAR and NAR (AUC 0.791; 95% CI
0.702, 0.880; P<0.001). Less than two positive clinical features resulted in 96% sensitivity (95% CI 0.78, 0.99) and a
LR- 0.09 (95% CI 0.02, 0.41) and four positive clinical features resulted in 95% specificity (95% CI 0.90, 0.98) and a
LR+ of 4.98 (95% CI 1.69, 13.84).
Conclusions: In this cohort of primary care patients with predominantly subacute or chronic ACJ pain of non-
traumatic onset, traditional ACJ tests were of limited diagnostic value. Combinations of other history and physical
examination findings were able to more accurately identify injection-confirmed ACJ pain in this cohort.
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Disorders of the acromioclavicular joint (ACJ) are a com-
mon cause of shoulder pain in primary care, affecting pa-
tients of all ages and levels of activity [1]. Acromioclavicular
joint pain has many causes including capsulo-ligamentous
injury and instability [2-4], degenerative or post-traumatic
arthropathy, inflammatory arthropathy [5], crystal arthrop-
athy and osteolysis [6].
The clinical diagnosis of painful ACJ disorders is im-
portant to enable efficient application of appropriate
treatment interventions and to inform decisions regard-
ing the need for further diagnostic investigations or spe-
cialist consultation. The clinical detection of painful ACJ
conditions also aids interpretation of the relevance of ab-
normal radiological findings, the prevalence of which is
known to be high in asymptomatic individuals [7]. De-
tection of painful ACJ conditions is also of prognostic
significance having been identified as one of the stron-
gest factors associated with reduced patient satisfaction
[8] and with reduced functional ability following rotator
cuff repair surgery [9].
While debate surrounds the accuracy of clinical tests
for the diagnosis for shoulder conditions such as
subacromial impingement [10,11] and glenoid labrum
tears [12], the clinical diagnosis of ACJ pain is consid-
ered to be less contentious with localised ACJ tender-
ness [13], the O’Brien’s/Active Compression test [13-15],
the cross-body adduction test [14,16] and the Hawkins-
Kennedy [13,14] frequently reported in diagnostic stud-
ies as index tests for identifying injection-confirmed ACJ
pain (Table 1). Despite moderate to high sensitivity and
specificity values for these tests, several methodological
considerations may influence the interpretation and sub-
sequent application of these results in the primary care
setting. Firstly, all patients in these studies were sampled
from either surgical settings [14-16] or from a specialist
shoulder referral centre [13]. The mechanism of injury
as well as the prevalence of painful ACJ conditions and
the severity of ACJ disease in these settings are likelyTable 1 Summary of previous studies investigating the diagn
pain and pathology
Test Author and Year Recruitment
Active Compression/O’Brien’s test O’Brien et al. 1998 [15] Orthopaedic h
Walton et al. 2004 [13] Specialist shou
Chronopoulos et al. 2004 [14] Orthopaedic s
Van Riet & Bell 2011 [16] Orthopaedic h
Cross-body adduction Chronopoulos et al. 2004 [14] Orthopaedic s
Van Riet & Bell 2011 [16] Orthopaedic h
Localised ACJ tenderness Walton et al. 2004 [13] Specialist shou
Hawkins Kennedy test Chronopoulos et al. 2004 [14] Orthopaedic s
Abbreviations: LR+, positive likelihood ratio; LR-, negative likelihood ratio; QUADAS,
applicable; N/R, not reported; ACJ, acromioclavicular joint.
aFrom Hegedus et al. (2008) [30].to differ considerably from patients presenting with
shoulder pain in primary health care. Differences in
prevalence (pre-test probability) and disease severity
(spectrum bias) are known to affect the performance of
diagnostic tests across populations in which these char-
acteristics differ [17] and the direct application of diag-
nostic accuracy probabilities obtained for ACJ tests in
surgical care settings to primary health care settings
may lead the clinician to an incorrect diagnostic con-
clusion potentially resulting in inappropriate manage-
ment pathways.
In addition, many of the studies [14-16] contained sev-
eral sources of bias that may influence the interpretation
of the findings [18]. In two previous studies that
reported the highest levels of diagnostic accuracy for
ACJ pain, blinding procedures were not reported
[14,15]. The reference standard used for identification of
ACJ pain in previous studies also varied or was incon-
sistently applied. Partial verification bias, incorporation
bias and selection bias were present in several studies
[14-16] and the positive anaesthetic response criteria va-
ried in all studies, ranging from >50% pain relief [13],
“complete or near complete relief” [14], or “all ACJ clin-
ical tests had to be negative following injection” [16],
making it difficult to compare results between studies.
These sources of bias may result in under- or overesti-
mation of diagnostic test performance [19].
The lack of diagnostic studies in primary care popula-
tions and the methodological concerns from previous
studies conducted in secondary care settings mean the
accuracy of clinical tests for identifying ACJ pain and
pathology in the primary care population is unknown
and previous results may be incorrectly interpreted or
wrongly applied. Hence, the purpose of this study was to
estimate the diagnostic accuracy of traditional ACJ tests
in a primary care population and compare their accuracy
with other clinical examination findings to determine
the most valid tests for identifying the ACJ as the pre-
dominant source of pain in a primary care setting.ostic accuracy of clinical tests for acromioclavicular joint
Sensitivity Specificity LR+ LR- QUADAS Scorea
ospital 93 96 23.1 0.08 5
lder referral centre 16 90 1.6 0.93 13
urgical waiting list 41 95 8.2 0.62 10
ospital 83 N/A N/A
urgical waiting list 77 79 3.67 0.29 10
ospital 67 N/A N/A N/R
lder referral centre 96 10 1.07 0.40 13
urgical waiting list 47 45 0.85 1.2 10
Quality Assessment of Diagnostic Accuracy Studies tool [45]; N/A, not
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Study design and setting
The study was designed using the STARD guide-
line principles [20]. Participants were recruited from
community-based medical and physiotherapy practices
across Christchurch, New Zealand. Ethical approval was
granted by the New Zealand Ministry of Health Regional
Ethics Committee (Upper South A) and written in-
formed consent was provided by all participants prior to
participation in the study.
Recruitment and sampling
Consecutive patients over the age of 18 years, presenting
to their primary care practitioner (general practitioner
or physiotherapist) for the first time with a new episode
of shoulder pain (Figure 1) and with the ability to follow
verbal instructions, were eligible for inclusion in the
study. Exclusion criteria were known fractures or dislo-
cations around the shoulder complex, referred pain from
the cervical spine, sensory or motor deficit involving the
upper limb, previous surgery to the shoulder or cervical
spine, or contraindications to imaging or injection pro-
cedures. Sample size was determined using methods for
estimates for diagnostic accuracy studies described by
Flahault et al. [21]. The minimum acceptable lower con-
fidence limit was set at 0.75 and expected sensitivity/
specificity were both set at 0.90.
Index tests
All participants completed self-report questionnaires
including the Shoulder Pain and Disability Index
(SPADI) [22], Global Disability Rating [23], SF-8™ health
survey [24], and Fear Avoidance Beliefs Questionnaire
(FABQ) [25]. All history and physical examination vari-
ables were selected according to evidence or clinical
relevance for subacromial and ACJ pathology. A full listFigure 1 Location of primary shoulder pain required for inclusion in tof clinical examination variables is presented in Additional
file 1. All clinical examinations were conducted by a
musculoskeletal physiotherapist with 20 years’ experience.
All participants recorded a standardised history in-
cluding medical and family history, smoking history, a
pain drawing, symptom duration and details of past his-
tory of shoulder pain, occupational, sporting and recre-
ational activities. Details of the mechanism of injury
were also recorded and coded as traumatic (external
force, fall or impact), strain (intrinsic stretch, reach or
lifting injury), repetitive (onset of pain during or within
48 hours of repetitive activity for which no other cause
was identified), or unknown.
The physical examination consisted of active range of
motion (ROM) of the cervical spine [26], inspection for
swelling or muscle atrophy, recording the presence of
a painful arc of motion during abduction [27], record-
ing of symptom responses associated with arm eleva-
tion (flexion), scapuloclavicular tests [28], passive ROM
glenohumeral abduction, external rotation performed at 0°
abduction and internal and external rotation performed at
90° of abduction [29], cross-body adduction, isometric
resisted muscle tests (abduction, external and internal ro-
tation), orthopaedic tests selected according to evidence
for reported diagnostic accuracy [30] and performed as
described by the original authors; Hawkins-Kennedy test
[31], active compression (O’Brien’s) test [15], and pain re-
sponses to palpation of the ACJ. Symptom responses were
recorded during all ROM and resisted tests according to
whether or not typical symptoms were reproduced.
During the physical examination, those tests provoca-
tive of typical pain were identified for use in pre- and
post-injection testing. Ambiguous or indeterminate re-
sults of clinical examination tests were recorded and
coded as missing data. Following the clinical examin-
ation, all participants received a standardised shoulderhe study.
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bursa diagnostic block as part of the larger diagnostic
accuracy study (Figure 2) [32].
Reference standard test
One week following the imaging investigations and
subacromial bursa injection, participants received a fluoro-
scopically guided injection of local anaesthetic into the
ACJ. Participants were positioned supine with the arm in
external rotation. Under aseptic conditions, a 22-gauge
needle was inserted into the ACJ using a direct anterior ap-
proach. Iodinated contrast (0.5 ml of Omnipaque 300 GE
Healthcare) was introduced and fluoroscopic images used
to confirm needle placement within the ACJ. Approxi-
mately 2 mL of 1% lidocaine hydrochloride (Xylocaine™)
was then injected into the joint. The radiologist recorded
whether the ACJ was successfully infiltrated and whether
the injectate was contained within the joint. This proced-
ure has been described in detail elsewhere [32].
Immediately prior to the injection, all participants were
examined using up to six tests identified during the clin-
ical examination as being provocative of typical symptoms.
Pre-injection pain intensity was recorded for each clinical
test on a 100 mm visual analogue scale (VAS; 0 mm “no
pain” and 100 mm “worst imaginable pain”). Tests were
repeated between 5 and 15 minutes following the injection
and pain intensity scores recorded again. Percent changeEligible
inclusi
(373Did not wish to participate 50
Exclusion criteria 57
Unavailable on required days 31
Symptoms resolved 15
Study capacity exceeded 12
Total: 165
Symptoms resolved 1
Symptoms resolved 1
Enrolle
stud
(208
Clinic
examina
(207
X-Ray & ultr
scan
(203
SAB inje
(202
ACJ
injecti
(188
Unable to get time off work 2
Failed to arrive for procedure 2
Withdrew (painflare) 4
Failed to arrive for procedure 3
Unavailable for procedure 3
Fracture/ dislocation detected 3
Procedure unable to be performed due
to morbidobesity 1
DROP OUT REASONS
NOT INCLUDED IN STUDY
Figure 2 Flow chart of study procedures, drop out explanations and
acromioclavicular joint; PAR, positive anaesthetic response.in pain intensity was calculated for each index test and the
average change in pain intensity from all clinical tests was
calculated. Positive integers (+) indicate increased post-
injection pain intensity, and negative integers (−) indicate
decreased post-injection pain intensity.
A positive anaesthetic response (PAR) was set at 80% or
more reduction in post-injection pain intensity. Higher
PAR cut-points have been shown to reduce the false-
positive response rate in patients with confounding factors
reporting spinal pain [33] and to produce high specificity
with regard to identification of the tissue origin of pain [34].
The 80% PAR criteria has also shown diagnostic stability at
2-year follow-up compared with lower PAR cut-points [35]
and is now considered the criterion standard for the selec-
tion of high quality studies for inclusion in systematic
reviews of diagnostic efficacy in spinal conditions in which
the use of diagnostic injections is well established [33].
The investigator performing the clinical examination
and pre- and post-injection clinical tests was blinded to
any diagnostic or treatment information from referring
practitioners and to imaging results. Radiologists were
not provided with any clinical information prior to the
imaging or injection procedures.
Statistical analysis
Sensitivity, specificity, positive and negative predictive
values, positive likelihood ratios (LR+), negative likelihood for
on
)
d in
y
)
al
tion
)
asound
)
ction
)
on
)
RESULTS of ACJ DIAGNOSTIC BLOCK
ACJ infiltrated & injectate contained 173
Pre-injectionpainintensity >20mm 20
Cases included in analysis 153
80% PAR reported 22
Adverse reactions reported (painflare) 5
adverse events. Abbreviations: SAB, subacromial bursa; ACJ,
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tions of traditional ACJ tests (Active Compression/
O’Brien’s test, cross-body adduction, ACJ palpation and
Hawkins-Kennedy test) using Confidence Interval Ana-
lysis (CIA) software (version 2.1.2) [36]. Likelihood ratios
were interpreted according to reported guidelines for
interpreting changes in probability of disease status (posi-
tive likelihood ratio: small (2.0 to 5.0), moderate (5.0 to
10.0), large (>10); negative likelihood ratio: small (0.2 to
0.5), moderate (0.1 to 0.2), large (<0.1)) [37]. Area under
the receiver operator curve with 95% confidence intervals
(CI) was calculated for combinations of traditional tests
using the Statistical Package for the Social Sciences (SPSS
version 17.0, IBM® Corporation 2010).
The Fisher exact test was performed on all clinical exam-
ination variables (Additional file 1) using the Statistical
Package for the Social Sciences (SPSS version 17.0, IBM®
Corporation 2010). The clinical examination variables that
demonstrated the strongest association with an 80% PAR
to ACJ diagnostic block were identified (P≤ .0.05) and the
diagnostic accuracy estimates for these clinical examination
variables was calculated as described above [36]. The diag-
nostic accuracy estimates for these clinical features were
then compared with the estimates for traditional ACJ tests
to determine the individual or combinations of clinical fea-
tures that were most accurate for identifying an 80% PAR
following ACJ diagnostic injection.
Results
Three hundred and seventy three patients were referred
to the study between July 2009 and June 2010 resulting
in 208 participants being included in the study. Reasons
for exclusion of patients in the study are presented in
Figure 2. There were no significant differences between
those included and excluded from the study with respect
to age or gender. Those excluded from the study repor-
ted shorter duration of symptoms (median 2 weeks; IQ
range 4 weeks) (Mann–Whitney P<0.001).
Two hundred and seven subjects completed the clin-
ical examination and 188 participants received the ACJ
diagnostic block. Demographic data for those who
underwent the ACJ diagnostic block are presented in
Table 2. A non-traumatic mechanism of injury was
reported by 62% of all participants (Table 2). Drop-out
explanations are presented in Figure 2. There were no
differences in demographic or self-report questionnaire
results between those who completed the study and
those who dropped out (P>0.05). Mean time between
the clinical examination and ACJ diagnostic block was
11 days (± 3 days), range 8 to 19 days.
Reference standard procedure
Average ACJ injection volume was 2.1 mL (SD 0.7 mL),
and the injectate was contained within the ACJ in 174cases (93%). Due to the known limitations of VAS scales
for measuring change in pain intensity when pre-
injection pain levels are low (<20 mm) [38], only cases
where pre-injection pain intensity exceeded 20 mm were
included in the analysis of anaesthetic response to diag-
nostic injections (n=153). A PAR (≥80% reduction in
post-injection pain intensity) was reported by 22 of the
153 participants (14%). The distribution of pathology
identified on diagnostic imaging investigations for the
PAR and negative anaesthetic response (NAR) groups is
presented in Table 3.
Accuracy of traditional acromioclavicular joint tests
The diagnostic accuracy results for traditional ACJ tests
are presented in Table 4. No traditional ACJ tests were
associated with a PAR following ACJ diagnostic block
(P<0.05). Sensitivity for traditional tests ranged from
0.14 (95% CI 0.05, 0.33) (Active Compression/O’Brien’s
test) to 0.70 (95% CI 0.48, 0.86) (Hawkins-Kennedy test).
Specificity ranged from 0.26 (95% CI 0.19, 0.35) (cross-
body adduction test) to 0.92 (95% CI 0.86, 0.96) (Active
Compression/O’Brien’s test). Positive likelihood ratios
ranged from 0.86 (cross-body adduction) to 1.73 (Active
Compression/O’Brien’s test) and negative likelihood ra-
tios ranged from 0.84 (Hawkins-Kennedy test) to 1.39
(cross-body adduction). Positive predictive values (PPV)
ranged from 0.13 to 0.23, with the largest change in
post-test probability (positive predictive value) for a PAR
observed for the Active Compression/O’Brien’s test
(0.23; 95% CI 0.08, 0.50) based upon a pre-test probabil-
ity (prevalence) of 0.14 (14%).
When the traditional tests were combined using mini-
mum numbers of positive tests, sensitivity was highest
(0.96; 95% CI 0.78, 0.99) when none of the tests were
positive and specificity was highest (0.99; 95% CI 0.95,
1.00) when all four tests were positive. The highest posi-
tive likelihood was 5.70 (95% CI 0.60, 52.63) (four posi-
tive tests) and the lowest negative likelihood ratio was
0.65 (95% CI 0.11, 3.54) (minimum of one positive test).
The largest change in post-test probability of a PAR was
observed when 4 tests were positive (PPV 0.50; 95% CI
0.10, 0.91). For the traditional ACJ tests, the area under
the receiver operator curve for the total number of posi-
tive tests was 0.507 (P=0.920; 95% CI: 0.366, 0.647).
Index tests
Five clinical variables were identified from the standar-
dised history and physical examination that were associ-
ated with an 80% PAR following ACJ diagnostic injection
(P≤0.05) (Table 5): repetitive mechanism of pain onset; the
absence of referred pain below the elbow; visual observa-
tion of a thickened or swollen ACJ; typical symptoms were
not reproduced or aggravated by passive GHJ abduction;
typical symptoms were not reproduced or aggravated by
Table 2 Demographic information
Participant characteristics All participants (N=188) PAR group (n=22) NAR group (n=131)
Mean (SD) Range Mean (SD) Mean (SD)
Age (years) 42 (13) 18 - 81 41 (13) 43 (14)
Height (cm) 172 (10) 147 - 199 170 (11) 172 (10)
Weight (kg) 80.4 (16.7) 50.3 – 135.4 78.5 (16.1) 80.4 (17.0)
Symptom duration (weeks)† 7 (14)† 0 – 175 6 (18)† 8 (14)†
Worst pain in last 48 hrs (100mm VAS scale) 62 (23) 3 – 100 59 (17) 65 (22)
SF8 physical component score (%) 44 (8) 23 – 61 45 (7) 44 (8)
SF8 mental component score (%)† 54 (11)† 27 – 66 57 (11)† 54 (10)†
SPADI pain score (%) 50 (22) 0 – 100 49 (15) 51 (21)
SPADI disability score (%)† 26 (30)† 0 – 96 26 (21)† 28 (30)†
SPADI total (%) 37 (20) 0 – 98 35 (13) 38 (21)
FABQ physical activity score (%) 65 (22) 0 – 100 64 (20) 65 (67)
FABQ work score (%)a† 21 (44)† 0 – 81 32 (47)† 21 (44)†
FABQ total score (%)a 41 (19) 0 – 87 45 (18) 41 (18)
% male gender 52 55 56
% right hand dominant 87 86 87
% dominant arm affected 52 36 55
% Pain onset: traumatic 38 32 40
% Pain onset: non-traumatic 62 68 61
% Pain onset: strain injury 40 36 41
% Pain onset: repetitive activity 13 27 10*
% Pain onset: insidious 9 5 10
Abbreviations. PAR, positive anaesthetic response (≥80% post-injection reduction in pain intensity); NAR, negative anaesthetic response (<80% reduction in post-
injection pain intensity); VAS, 100 mm visual analogue pain score in previous 48 hours; SPADI, Shoulder Pain & Disability Index; FABQ, Fear Avoidance
Beliefs Questionnaire.
aonly cases ‘in paid employment’ used in analysis.
†Variables were not normally distributed. Median (interquartile range) values are presented.
*P<0.05.
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tion). Missing data for these variables was less than 5%.
Sensitivity estimates for these clinical variables ranged
from 0.27 (repetitive mechanism of injury; 95% CI 0.13,
0.48) to 1.00 (no referred pain below the elbow; 95% CI
0.84, 1.00). Specificity ranged from 0.18 (no referred pain
below the elbow; 95% CI 0.12, 0.26) to 0.90 (repetitive
mechanism of injury; 95% CI 0.84, 0.94). The highest
positive likelihood ratio was recorded when passive ex-
ternal rotation performed at 90° abduction did not re-
produce typical symptoms (2.83; 95% CI 1.56, 4.76) and
the lowest negative likelihood ratio for an 80% PAR oc-
curred when pain did not refer below the elbow (0.00;
95% CI 0.00, 0.92). Compared with the pre-test probabil-
ity of 14%, the largest change in post-test probability
(positive predictive value) of a PAR (0.32) was observed
for pain onset due to repetitive activity (95% CI 15, 54)
and the absence of pain during passive external rotation
performed at 90° abduction (95% CI 0.19, 0.49).
When the history and physical examination findings
were combined, highest sensitivity (1.00; 95% CI 0.85,1.00) and lowest LR- (0.00; 95% CI 0.00, 2.15) were ob-
served when none of the findings were positive, and
highest specificity (0.95; 95% CI 0.90, 0.98) and LR+
(4.98; 95% CI 1.69, 13.84) occurred when four or more
tests were positive (Table 6). None of the participants
recorded positive responses for all five clinical features.
Compared with a pre-test probability of 14%, the largest
change in post-test probability (positive predictive value)
for a PAR was observed when at least four of the five
tests were positive (0.46). Area under the receiver oper-
ator curve for the total number of positive clinical tests
was 0.791 (P<0.001; 95% CI: 0.702, 0.880). These diag-
nostic accuracy results have been summarized into a
guideline that may be used to assist diagnostic decision
making in clinical practice (Figure 3).
Discussion
These results provide preliminary evidence that trad-
itional ACJ tests considered to be diagnostic for ACJ
pain were of limited diagnostic value in a cohort of pri-
mary care patients with predominantly subacute or
Table 3 Distribution of diagnostic imaging results
Diagnostic test results Total
identified
(N=153)
% in PAR
group with
pathology
(n=22)
% in NAR
group with
pathology
(n=131)
n (%) % %
X-ray
ACJ pathology 21 (14) 23 12
ACJ arthropathy 18 (12) 18 11
ACJ osteolysis 6 (4) 5 4
GHJ pathology 7 (5) 0 5
Rotator cuff calcification 19 (12) 5 14
supraspinatus 11 (7) 5 8
infraspinatus 7 (5) 0 5
subscapularis 6 (4) 0 5
Ultrasound
SAB pathology 105 (69) 55 71
Rotator cuff tear 46 (30) 14 33
supraspinatus 38 (25) 14 27
infraspinatus 3 (2) 0 2
subscapularis 10 (7) 0 8
Rotator cuff tendinosis 21 (14) 9 15
supraspinatus 20 (13) 9 14
infraspinatus 1 (1) 0 1
subscapularis 1 (1) 0 1
Rotator cuff calcification 35 (23) 18 24
supraspinatus 22 (14) 18 14
infraspinatus 9 (6) 0 7
subscapularis 15 (10) 5 11
LHB tear or tendinosis 6 (4) 5 4
Biceps tendon sheath effusion 21 (14) 9 15
ACJ pathology 35 (23) 41 20
GHJ effusion 6 (4) 0 5
Abbreviations. ACJ, acromioclavicular joint; PAR, positive anaesthetic response
(≥80% post-injection reduction in pain intensity); NAR, negative anaesthetic
response (<80% reduction in post-injection pain intensity); GHJ, glenohumeral
joint; SAB, subacromial bursa; LHB, long head of biceps.
Note: There were no statistically significant differences in frequency of imaging
findings between the PAR and NAR groups (P>0.05).
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of other history and physical examination findings were
able to more accurately identify ACJ pain in this cohort.
Results of this study represent predominantly non-
traumatic ACJ pain. For the purposes of this study,
trauma was defined as an involving an ‘external force,
impact or fall’, and 62% of participants reported that the
onset of their pain was not associated with a traumatic
event. Due to the nature of the reference standard pro-
cedure used in this study (intra-articular ACJ diagnostic
injection), a valid reference standard outcome requiredan intact joint capsule to minimise the possibility of an-
aesthetisation of extra-articular ACJ structures that may
produce a false-positive result. For this reason, frank
ACJ instabilities such as subluxations or dislocations
were excluded from our study. It is possible that partici-
pants with more subtle ACJ capsulo-ligamentous injuries
were included in the study, but the subsequent use of
fluoroscopy during the injection procedure enabled ex-
clusion from analysis those cases in which the joint cap-
sule was compromised, evidenced by the injectate
breaching the ACJ capsular margins. For these reasons,
our results reflect patients in whom the ACJ capsulo-
ligamentous complex is largely intact, and cannot be
generalised to those patients with traumatic ACJ capsulo-
ligamentous disruption.
The highest levels of diagnostic accuracy for identify-
ing a predominant ACJ pain source in this primary care
study were observed for combinations of five history and
physical examination variables: repetitive mechanism of
pain onset, absence of referred pain below the elbow, a
thickened or swollen ACJ and the absence of typical pain
provocation during passive GHJ abduction and external
rotation (performed at 90° abduction). The area under
the receiver operator curve (AUC) indicated that combi-
nations of these five clinical features were considerably
more accurate in identifying those likely to report an
80% PAR (predominant ACJ pain source) than trad-
itional ACJ tests. For those participants who reported
less than two of the five positive clinical features, the
likelihood of an 80% PAR (predominant ACJ pain
source) was very low (LR- 0.09; 95% CI 0.02, 0.41). Com-
bined with high sensitivity (0.96; 95% CI 0.78, 0.99), the
presence of less than two positive clinical features may
assist in ruling-out a predominant ACJ pain source with
moderate to high levels of confidence.
Combinations of these clinical features were also of
value for positively identifying those who were likely to re-
port an 80% PAR (predominant ACJ pain source). When
four positive clinical features were identified, participants
were almost five times more likely to report a PAR (LR+
4.98; 95% CI 1.69, 13.84) than those for whom less than
four clinical features were identified. Specificity was also
high (0.95; 95% CI 0.90, 0.98) indicating a low false posi-
tive rate when four of the five clinical features were
present. These results support previous findings of im-
proved diagnostic accuracy using combinations of clinical
examination findings, compared with individual physical
examination tests for painful ACJ conditions [14]. Figure 3
presents a diagnostic decision guideline that may aid
utilization of these results in clinical practice.
This study identified several history and physical exam-
ination features that, to our knowledge, have not previ-
ously been reported as diagnostically useful for ACJ pain.
The onset of pain due to repetitive activity demonstrated
Table 4 Diagnostic accuracy of traditional tests for acromioclavicular joint pain
Clinical tests Cell counts Diagnostic accuracy
TP FN FP TN Sensitivity
(95% CI)
Specificity
(95% CI)
PPV
(95% CI)
NPV
(95% CI)
LR+
(95% CI)
LR-
(95% CI)
OR
(95% CI)
Individual tests
Cross-body adduction 14 8 93 33 0.64 (0.43, 0.80) 0.26 (0.19, 0.35) 0.13 (0.08, 0.21) 0.81 (0.66, 0.90) 0.86 (0.58, 1.12) 1.39 (0.71, 2.43) 0.62 (0.24, 1.61)
Active Compression/
O’Brien’s test
3 19 10 117 0.14 (0.05, 0.33) 0.92 (0.86, 0.96) 0.23 (0.08, 0.50) 0.86 (0.79, 0.91) 1.73 (0.53, 5.15) 0.94 (0.72, 1.06) 1.85 (0.47. 7.33)
Hawkins-Kennedy test 14 6 81 45 0.70 (0.48, 0.86) 0.36 (0.28, 0.44) 0.15 (0.09, 0.23) 0.88 (0.77, 0.95) 1.09 (0.74, 1.41) 0.84 (0.39, 1.55) 1.30 (0.47, 3.61)
Localised ACJ tenderness 8 14 34 94 0.36 (0.20, 0.57) 0.73 (0.65, 0.80) 0.19 (0.10, 0.33) 0.87 (0.79, 0.92) 1.37 (0.70, 2.39) 0.87 (0.58, 1.13) 1.58 (0.61, 4.10)
Combinations of tests
At least 1 of 4 21 1 120 9 0.96 (0.78, 0.99) 0.07 (0.04, 0.13) 0.15 (0.10, 0.22) 0.90 (0.60, 0.98) 1.03 (0.84, 1.11) 0.65 (0.11, 3.54) 1.58 (0.19, 13.09)
At least 2 of 4 11 9 77 43 0.55 (0.34, 0.74) 0.36 (0.28, 0.45) 0.13 (0.07, 0.21) 0.83 (0.70, 0.91) 0.86 (0.53, 1.20) 1.26 (0.69, 2.01) 0.68 (0.26, 1.78)
At least 3 of 4 6 14 22 93 0.30 (0.15, 0.52) 0.81 (0.73, 0.87) 0.21 (0.10, 0.40) 0.87 (0.79, 0.92) 1.57 (0.70, 3.13) 0.87 (0.59, 1.09) 1.81 (0.63, 5.25)
4 of 4 1 19 1 113 0.05 (0.01, 0.24) 0.99 (0.95, 1.00) 0.50 (0.10, 0.91) 0.86 (0.79, 0.91) 5.70 (0.60, 52.63) 0.96 (0.77, 1.01) 5.95 (0.36, 99.19)
Abbreviations. TP, true positives; FN, false negatives; FP, false positives; TN, true negatives; CI, confidence interval; PPV, positive predictive value; NPV, negative
predictive value; LR+, positive likelihood ratio; LR-, negative likelihood ratio; OR, odds ratio.
Note: Cell counts do not total 153 in some cases due to missing data.
All P-values for the OR were >0.05 (not significant).
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Other literary references to repetitive injury mechanisms
in the diagnosis of shoulder pain relate to osteolysis of the
distal clavicle that causes pain in the region of the ACJ
[39,40]. Although 24 participants reported the onset of
pain related to repetitive activity in our study, there were
only six cases in which the radiographic finding of osteoly-
sis was reported. Hence, while the high specificity suggests
this finding may help to rule-in ACJ pain, other painful
shoulder conditions may also result from, or become ag-
gravated by repetitive activity and this finding must be
interpreted with caution with respect to assumptions re-
garding the underlying pathology.
The relationship between the absence of pain during
passive glenohumeral joint abduction and external rota-
tion (performed at 90° abduction) and ACJ pain were
new and potentially important findings. The provocationTable 5 Diagnostic accuracy of individual history and physica
acromioclavicular joint diagnostic block
Clinical examination
variables
Cell counts
TP FN FP TN Sensitivity
(95% CI)
Specificity
(95% CI)
PPV
(95
Onset: repetitive
activity
6 16 13 118 0.27 (0.13, 0.48) 0.90 (0.84, 0.94) 0.32
No pain referred
below elbow
20 0 105 23 1.00 (0.84, 1.00) 0.18 (0.12, 0.26) 0.16
ACJ thickened or
swollen
15 5 47 77 0.75 (0.53, 0.89) 0.62 (0.53, 0.70) 0.24
PROM GHJ abduction –
no pain
8 14 18 108 0.36 (0.20, 0.57) 0.86 (0.79, 0.91) 0.31
PROM ER900 – no pain 11 11 23 107 0.50 (0.31, 0.69) 0.82 (0.75, 0.88) 0.32
Abbreviations. TP, true positives; FN, false negatives; FP, false positives; TN, true neg
predictive value; LR+, positive likelihood ratio; LR-, negative likelihood ratio; OR, odd
glenohumeral joint; ER 90°, external rotation performed in 90° of abduction.
Note. Cell counts do not total 153 in some cases due to missing data.
*P<0.05; ** P<0.01.of pain during passive glenohumeral joint abduction and
external rotation is commonly associated with symptom-
atic glenohumeral capsuloligamentous or intra-articular
pathology [41-43]. Despite modest LR+ (2.6 and 2.8 re-
spectively), the absence of symptom provocation during
GHJ abduction and external rotation resulted in the lar-
gest improvement in the post-test probability of an 80%
PAR (predominant ACJ pain source) of all traditional
ACJ tests and other clinical examination features investi-
gated in this study. Given the diverse nature of shoulder
pain seen in primary care, and the lack of specificity of
clinical tests for many shoulder conditions, the exclusion
of diagnostic possibilities with the help of ‘negative tests’
may assist in narrowing the range of differential diagno-
ses representing a more realistic approach to diagnostic
reasoning for the shoulder than the pursuit of the ‘magic
bullet’ test with high specificity for shoulder disorders.l examination variables for a positive response to
Diagnostic accuracy
% CI)
NPV
(95% CI)
LR+
(95% CI)
LR-
(95% CI)
OR
(95% CI)
(0.15, 0.54) 0.88 (0.82, 0.93) 2.75 (1.15, 6.07) 0.81 (0.57, 0.98) 3.4* (1.1, 10.2)
(0.11, 0.23) 1.00 (0.86, 1.00) 1.22 (1.18, 1.34) 0.00 (0.00, 0.92) 0.84* (0.78, 0.91)
(0.15, 0.36) 0.94 (0.87, 0.97) 1.98 (1.33, 2.70) 0.40 (0.28, 0.77) 4.9** (1.7, 14.4)
(0.17, 0.50) 0.89 (0.82, 0.93) 2.55 (1.23, 4.86) 0.74 (0.50, 0.95) 3.4* (1.3, 9.3)
(0.19, 0.49) 0.91 (0.84, 0.95) 2.83 (1.56, 4.76) 0.61 (0.37, 0.85) 4.7** (1.8, 12.0)
atives; CI, confidence interval; PPV, positive predictive value; NPV, negative
s ratio; ACJ, acromioclavicular joint; PROM, passive range of motion; GHJ,
Table 6 Diagnostic accuracy of combinations of history and physical examination variables for a positive response to
acromioclavicular joint diagnostic block
Number of
positive
clinical testsa
Cell counts Diagnostic accuracy
TP FN FP TN Sensitivity
(95% CI)
Specificity
(95% CI)
PPV
(95% CI)
NPV
(95% CI)
LR+
(95% CI)
LR-
(95% CI)
OR
(95% CI)
One or more 22 0 116 9 1.00 (0.85, 1.00) 0.07 (0.04, 0.13) 0.16 (0.11, 0.23) 1.00 (0.70, 1.00) 1.08 (1.07, 1.15) 0.00 (0.00, 2.15) 0.84 (0.78, 0.90)
Two or more 21 1 61 70 0.96 (0.78, 0.99) 0.53 (0.45, 0.62) 0.26 (0.17, 0.36) 0.99 (0.92, 1.00) 2.05 (1.61, 2.52) 0.09 (0.02, 0.41) 24.10*** (3.15, 184.45)
Three or more 12 10 22 109 0.55 (0.35, 0.73) 0.83 (0.76, 0.89) 0.35 (0.22, 0.52) 0.92 (0.85, 0.95) 3.25 (1.83, 5.40) 0.55 (0.32, 0.79) 5.95*** (2.29, 15.47)
Four or more 5 17 6 125 0.23 (0.10, 0.43) 0.95 (0.90, 0.98) 0.46 (0.21, 0.72) 0.88 (0.82, 0.92) 4.98 (1.69, 13.84) 0.81 (0.59, 0.95) 6.13** (1.69, 22.27)
Five or more 0 22 0 131 † † † † † † †
Abbreviations. TP, true positives; FN, false negatives; FP, false positives; TN, true negatives; CI, confidence interval; PPV, positive predictive value; NPV, negative
predictive value; LR+, positive likelihood ratio; LR-, negative likelihood ratio; OR, odds ratio.
Note: Cell counts do not total 153 in some cases due to missing data.
aAny combination of the following positive tests: onset of pain due to repetitive activity; no pain referral below elbow; ACJ thickened or swollen; typical
symptoms are not provoked during PROM GHJ abduction or PROM external rotation (90° abduction).
† Invalid calculation (no participants reported five positive clinical tests).
** P≤0.01; *** P≤0.001.
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Traditional ACJ tests were of limited diagnostic value
for identifying those with a predominant ACJ pain
source in this primary care cohort. Of the traditional
tests, the positive likelihood ratio of the Active Com-
pression/O’Brien’s test was only 1.73, with a lower 95%
confidence limit of 0.53, reducing confidence that a posi-
tive test improved the likelihood of a PAR in individual
patients above the level of ‘chance’ (1.0). These results
are similar to those reported by Walton et al. (2004) (LR
+ 1.6) in a small cohort of patients (n=38) referred to a
specialist shoulder centre [13]. Other authors, including
those who developed the test [15] have reported larger
positive likelihood ratio values for the Active Compres-
sion test (8.2 and 23.1) [14,15], however the sample sizeHow many of the following are present?:
Pain onset due to repetitive activity
No pain referred below elbow
ACJ thickened or swollen
No pain with passive GHJ abduction
No pain with passive ER at 90o abd
Figure 3 Diagnostic decision guideline for identifying pain arising fro
diagnostic value for identifying a predominant acromioclavicular joint pain
anaesthetic into the acromioclavicular joint. Abbreviations: ACJ, acromioclav
the 80% pain reduction standard, based upon pre-test probability (prevalen
external rotation; abd, abduction; spec, specificity.was small in one study [14] and no confidence intervals
were reported in either of the studies. Traditional ACJ
tests resulted in only a marginal increase in post-test
probability for a PAR (13% to 23%) in the current study,
with the pre-test probability (14%) contained within the
PPV 95% confidence interval of all traditional tests.
When the four traditional ACJ tests were combined,
the 95% confidence intervals for the positive and nega-
tive likelihood ratios all spanned 1.0 and do not provide
sufficient confidence for accurate diagnosis. Although
combinations of four positive tests improved the post-
test probability to 50%, the confidence interval (0.10,
0.91) included the pre-test probability of 14% limiting
confidence in an improvement in the ability to identify
ACJ pain.Referred pain below elbow
0-1 Rule-Out ACJ
Sens 100%; PTP 0%
≤ 2 ACJ pain unlikely
Sens 96%; PTP 1%
3 ACJ pain more likely
Spec 83%; PTP 35%
4 ACJ pain very likely
Spec 95%; PTP 46%; LR+ 5.0
Yes
m the acromioclavicular joint. Clinical tests found to be of most
source defined by ≥80% pain relief following injection of local
icular joint; sens, sensitivity; PTP, post-test probability of ACJ pain at
ce) of 14%; HBB, hand-behind-back; GHJ, glenohumeral joint; ER,
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the Active Compression/O’Brien’s, and other traditional
ACJ tests as valuable diagnostic tests for ACJ pain in
primary health care settings may have been premature.
Acceptance of these tests as valuable diagnostic tools for
ACJ pain in clinical practice appears to have been based
upon the results of a small number of studies that
reported high sensitivity or specificity values for
injection-confirmed ACJ pain (Table 1) [13-16]. While
sensitivity and specificity provide a useful indication of
probability of a positive or negative clinical test result in
those known to have a condition (e.g. ACJ pain), likeli-
hood ratios are considered more powerful indicators of
disease status in individual patients when their condition
is unknown which is more reflective of clinical practice
[17]. In previous studies, the positive and negative likeli-
hood ratios appear to provide little supporting evidence
of a meaningful change in the probability of ACJ pain or
pathology despite high reported point estimates of sensi-
tivity and specificity. For instance, despite a reported
specificity of 90% for the Active Compression/O’Brien’s
test, the LR+ was only 1.6 (confidence intervals, and
contingency table not reported) [15] and localised ACJ
tenderness was reported to be 96% sensitive, however
the LR- was 0.40 (confidence intervals and contingency
table not reported) [13] providing little confidence in the
ability to rule-out ACJ pain when tenderness was not
elicited. This highlights the importance of interpreting
all reported diagnostic values along with estimates of
precision prior to accepting tests into clinical practice.
In contrast to previous results in secondary and tertiary
care populations [13,14,16], localised ACJ tenderness to
palpation and the cross-body adduction test were not
strongly associated with a PAR to ACJ diagnostic block in
this primary care cohort. In addition to the issues sur-
rounding interpretation of diagnostic test values, these
findings may relate to differences in disease severity in our
study compared with previous work [19]. In previous stud-
ies investigating the accuracy of clinical tests for ACJ pain,
patients were recruited from surgical waiting lists (patients
awaiting distal clavicle excision) [14] or from specialist
shoulder centres [13] in which the severity and duration
of ACJ disease are likely to differ considerably from pri-
mary care patients presenting for the first time with a new
episode of shoulder pain (inclusion criteria in the current
study). Pain provocation during the cross-body adduction
test and the ability to provoke symptoms of ACJ pain with
manual palpation may be influenced by the type and se-
verity of pathology and corresponding levels of mechanical
and chemical sensitisation providing a possible explan-
ation for this finding. Disease severity is thus likely to limit
the generalisability of diagnostic accuracy results obtained
in secondary and tertiary care settings, to primary care pa-
tients, and vice versa [13,14].Limitations
There were some limitations to consider in the current
study. Despite previous reliability testing for physical
examination tests used in this study [44], the interobserver
reliability of the history variables and observation of ACJ
swelling or thickening requires further evaluation. Fur-
thermore, the use of strict cut-off criteria for a PAR may
eliminate cases where the result may still produce a clinic-
ally meaningful outcome and on-going analyses will be
conducted in which various anaesthetic response levels
will be used as outcome variables. The number of PAR
cases was also relatively small and validation of these re-
sults in a larger sample is required.
Conclusions
In conclusion, traditional ACJ tests were of limited diag-
nostic value for identifying the ACJ as the predominant
source of pain in a cohort of primary care patients.
Combinations of several other history and physical
examination findings including pain referral patterns,
mechanism of pain onset and passive range of motion
tests appear to be of more diagnostic value for identify-
ing painful ACJ conditions in a sample of primary care
patients with predominantly non-traumatic shoulder
pain. This may aid early and accurate identification of
symptomatic ACJ pathology in primary health care en-
abling more efficient application of appropriate treat-
ment interventions.
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